ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,520 | -18.9% | 3,582 | -9.0% | 0.06% | -16.4% |
| Q2 2023 | $112,884 | -12.3% | 3,936 | -26.7% | 0.07% | -5.6% |
| Q1 2023 | $128,647 | +2.1% | 5,367 | -27.8% | 0.07% | +7.6% |
| Q4 2022 | $126,030 | +5.0% | 7,431 | -8.2% | 0.07% | +37.5% |
| Q3 2022 | $120,000 | -5.5% | 8,092 | +0.7% | 0.05% | +2.1% |
| Q2 2022 | $127,000 | +4.1% | 8,039 | +77.4% | 0.05% | -14.5% |
| Q1 2022 | $122,000 | -31.5% | 4,532 | -5.6% | 0.06% | -17.9% |
| Q4 2021 | $178,000 | -37.1% | 4,803 | -18.8% | 0.07% | -46.4% |
| Q3 2021 | $283,000 | +34.1% | 5,913 | -5.1% | 0.12% | +43.7% |
| Q2 2021 | $211,000 | +83.5% | 6,229 | +123.7% | 0.09% | +77.6% |
| Q1 2021 | $115,000 | -3.4% | 2,785 | +1.5% | 0.05% | 0.0% |
| Q4 2020 | $119,000 | – | 2,743 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |